Earnings Feed
Start Free
Amneal Pharmaceuticals, Inc.·4

May 8, 5:46 PM ET

TERRERI PETER R 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 8, 2019

Insider Transaction Report

Form 4
Period: 2019-05-06
Amneal Pharmaceuticals, Inc.AMRX
TERRERI PETER R
Director
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2019-05-08+6,107→ 76,299 total
  • Award

    Stock Option

    [F2]
    2019-05-06+28,044→ 28,044 total
    Exercise: $14.05Exp: 2029-05-06→ Class A Common Stock (28,044 underlying)
  • Award

    Restricted Stock Units

    [F1][F3]
    2019-05-06+6,459→ 6,459 total
    → Class A Common Stock (6,459 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F4]
    2019-05-08−6,107→ 0 total
    → Class A Common Stock (6,107 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
  • [F3]Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.
  • [F4]On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.
Signature
/s/ Brian P. Spitser, Attorney-in-Fact|2019-05-08

Documents

1 file
  • 4
    wf-form4_155735197842483.xmlPrimary

    FORM 4